Succinylcholine Chloride Recall: Dr. Reddy's (Lot K250048)
Announced 2025-12-17 · FDA
The recall concerns Succinylcholine Chloride Injection, USP, 200 mg/10 mL, 25 x 10 mL vials, Rx Only, distributed nationwide in the USA. The trigger was an out-of-specification result during the 6-month stability testing with decreased preservative concentration. A total of 571 vials are involved in this recall, identified by Lot # K250048.
| Brand | Dr. Reddy's Laboratories, Inc. |
|---|---|
| Product | Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25 |
| Reason | Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration. |
| Severity | moderate |
| Units affected | 4800 |
| Distribution | Nationwide within the USA. |
| Agency | FDA |
| Recall / campaign no. | Lot # K250048 |
WHAT YOU SHOULD DO
- Do not use any affected vials and verify your lot number (K250048) against your product.
- Contact your healthcare provider or pharmacist for guidance on replacement or returns.
- If you have the affected vials, follow disposal or return instructions provided by your supplier or local regulations.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.